← Back
$AKRO All transactions

Akero Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

5,161

Price

$0

Filed

Sep 10

Insider

Name

Rolph Timothy

Title

Chief Scientific Officer

CIK

0001779479

Roles

Officer

Transaction Details

Transaction Date

2025-09-08

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated August 12, 2024, previously adopted by the Reporting Person. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.855 to $44.72, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. | The options are vested and currently exercisable.

Filing Info

Accession No.

0001779479-25-000007

Form Type

4

Issuer CIK

0001744659

Rolph Timothy's History

Date Ticker Type Value
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D

Other Insiders at AKRO (90d)

No other insider activity at this issuer in the last 90 days.